Enhancing the well-being of autistic youth Mental and Behavioural Disorders
Conditions
Interventions
Current interventions as of 13/06/2025:
Upon providing informed consent, participants will be randomized into one of two conditions using a random number generator: Those in the "Treatment" condition
Sponsors
York University
Eligibility
Sex/Gender
All
Age
16 Years to 25 Years
Inclusion criteria
Inclusion criteria: 1. A formal diagnosis or self-identified diagnosis of autism (e.g., autism spectrum disorder) 2. Between the ages of 16-25 years
Exclusion criteria
Exclusion criteria: 1. Presence of a disorder that would make it too difficult or unsafe to participate 2. Previous participation in therapeutic photography intervention 3. Level of support need or intellectual impairment that cannot be supported by a companion
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Current primary outcome measures as of 13/06/2025: 1. Psychological well-being is measured using three Likert scales (EPOCH Measure of Adolescent Well-being, The PERMA-Profiler, The PROMIS-MP: The Meaning and Purpose Scale, and the Mental Health Continuum Short Form) at baseline and 5 weeks 2. Physiological well-being is measured using resting Heart Rate Variability (HRV) at baseline and 5 weeks Previous primary outcome measures: 1. Psychological well-being is measured using three Likert scales (EPOCH Measure of Adolescent Well-being, The PERMA-Profiler, and the Mental Health Continuum Short Form) at baseline and 5 weeks (all), and 10 weeks (WC group only) 2. Physiological well-being is measured using resting Heart Rate Variability (HRV) at baseline and 5 weeks (all), and 10 weeks (WC group only) | — |
Secondary
| Measure | Time frame |
|---|---|
| Current secondary outcome measures as of 13/06/2025: Secondary outcome measures 1. Anxiety symptoms will be measured using a Likert scale (GAD-7: The Generalized Anxiety Disorder 7-item Scale) at baseline and 5 weeks (all), and 10 weeks (WC group only). 2. Depressed mood symptoms will be measured using a Likert scale (PHQ-9: The Patient Health Questionnaire 9-item Scale) at baseline and 5 weeks (all), and 10 weeks (WC group only). 3. Meaning and purpose will be measured using a Likert scale (PROMIS-MP: The Meaning and Purpose Scale) at baseline and 5 weeks (all), and 10 weeks (WC group only). 4. Emotion regulation will be measured using a Likert scale (ER-Q: The Emotion Regulation Questionnaire) at baseline and 5 weeks (all), and 10 weeks (WC group only). 5. Savouring experiences will be measured using a Likert scale (SBI: The Savouring Beliefs Inventory) at baseline and 5 weeks (all), and 10 weeks (WC group only). 6. Physiological reactivity will be measured using Heart Rate Variability withdrawal (resting HRV at baseline minus HRV during a computerized tracing task) at 5 weeks (all). 1. Anxiety symptoms will be measured using a Likert scale (GAD-7: The Generalized Anxiety Disorder 7-item Scale) at baseline and 5 weeks 2. Depressed mood symptoms will be measured using a Likert scale (PHQ-9; The Patient Health Questionnaire 9-item Scale) at baseline and 5 weeks 4. Emotion regulation will be measured using a Likert scale (ER-Q: The Emotion Regulation Questionnaire) at baseline and 5 weeks 5. Savouring experiences will be measured using a Likert scale (SBI: The Savouring Beliefs Inventory) at baseline and 5 weeks 6. Physiological reactivity will be measured using Heart Rate Variability withdrawal (resting HRV at baseline minus HRV during a computerized tracing task) at 5 weeks. 7. The acceptability and feasibility of the intervention is measured using three Likert Scales (IAS: Implementation Acceptability Scale, FIM: Feasibility of Intervention Measure, AIM: Acceptabi | — |
Countries
Canada
Contacts
Public ContactJonathan Weiss
Outcome results
None listed